The Food and Drug Administration on Thursday approved a core component of a brain implant made by Precision Neuroscience, a company created by a cofounder of Elon Musk’s Neuralink that claims ...

Neuralink said that its human trials will be started soon. He appealed to the general public to participate in this mission, "If you or any of your loved ones have lost the ability to speak, you ...

Reuters reports that Neuralink raised another $600 million in a deal that values the company at $9 billion before the ...

Neuralink last year received "breakthrough device" clearance from the U.S. FDA. Three people have so far received implants ...

While the designation does not guarantee approval, it highlights the device's potential for "substantial" patient benefits and accelerates its path to commercialization, the FDA notes. Neuralink ...

The company celebrated news of its FDA approval with a simple post on X ... and why’s it different from earlier Neuralink experiments? Neuralink’s breakthrough device involves threading ...

This briefing covers health-related developments worldwide, including Sanofi's vaccine initiatives in Vietnam, Roche's ...

(Reuters) - Elon Musk's brain implant company Neuralink raised $600 million at a valuation of $9 billion, Semafor reported on ...

Precision announced it will expand its clinical research program for the implant, after the company had already tested the device in 37 patients, as the FDA’s approval allows Precision to ...

Elon Musk's brain-mapping venture, Neuralink, recently raised $600 million, boosting its valuation to a staggering $9 billion ...